Approval · Notice of Compliance 242 · 2002
OPTISON: Notice of Compliance 242
Issued June 6, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 242
- Date
- June 6, 2002
- Company
- Tyco HealthcarePointe-Claire, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Intravenous ultrasound contrast medium
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPTISON | 02239574 | Cancelled Post Market |
Medicinal ingredients
- ALBUMIN (HUMAN) 5 PER